Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal response to maternal methadone administration.

Lauren M Jansson1, Janet Dipietro, Andrea Elko

  • 1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ljansson@jhmi.edu

American Journal of Obstetrics and Gynecology
|September 10, 2005
PubMed
Summary

Maternal methadone use significantly impacts fetal neurobehavior. This study found reduced fetal heart rate variability and motor activity, independent of maternal physiological changes, highlighting potential risks to developing fetuses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of Dyadic Care to Support Clinical, Administrative, and Service Wraparound Needs for the Opioid-Exposed Mother and Infant.

Journal of addiction medicine·2026
Same author

Prenatal Opioid Exposure: Have We Lost an Opportunity to Improve the Outcomes of Mothers and Their Infants?

Clinical therapeutics·2025
Same author

Prenatal buprenorphine/naloxone exposure and neonatal neurobehavioral functioning: A preliminary report.

Neurotoxicology and teratology·2024
Same author

Gestational buprenorphine-naloxone exposure and fetal neurobehavior.

Neurotoxicology and teratology·2024
Same author

Clinically defining the opioid-exposed birthing person and infant as a dyad to support bedside care, surveillance, and research.

Frontiers in pediatrics·2024
Same author

A Dyadic Framework of Care for Opioid-exposed Birthing Persons and Their Infants and Children.

The Journal of pediatrics·2023

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Neurobehavior
  • Pharmacology

Background:

  • Opioid use in pregnancy presents challenges for maternal and fetal health.
  • Methadone is a common treatment for opioid use disorder during pregnancy.
  • Understanding methadone's impact on fetal development is crucial.

Purpose of the Study:

  • To investigate the effects of maternal methadone administration on fetal neurobehavioral functions.
  • To assess maternal physiological indicators during methadone treatment.
  • To determine if observed fetal effects are independent of maternal changes.

Main Methods:

  • Evaluation of 40 pregnant women receiving methadone treatment.
  • Assessment of fetal measures: heart rate, variability, accelerations/decelerations, motor activity, and movement-heart rate coupling.

Related Experiment Videos

  • Measurement of maternal indicators: heart period, variability, skin conductance, respiration, and respiratory sinus arrhythmia (RSA).

    • Main Results:

    • Peak methadone levels correlated with slower, less variable fetal heart rate and fewer accelerations.
    • Fetal motor activity and the coupling between fetal heart rate and motor activity were reduced.
    • Maternal heart rate and skin conductance remained unchanged; however, respiratory rate and RSA (parasympathetic tone) decreased.

    Conclusions:

    • Maternal methadone administration exerts significant, independent effects on fetal neurobehavioral functions.
    • These findings suggest potential neurodevelopmental implications for fetuses exposed to methadone.
    • Further research is warranted to explore long-term consequences.